Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Focused on new deals, Biogen bags a PhIII drug for ischemic stroke with $120M upfront
Focused on new deals, Biogen bags a PhIII drug for ischemic stroke with $120M upfront
Focused on new deals, Biogen bags a PhIII drug for ischemic stroke with $120M upfront
Submitted by
admin
on May 15, 2017 - 9:03am
Source:
Endpoints
News Tags:
Biogen
ischemic stroke
CIRARA
Remedy Pharmaceuticals
Headline:
Focused on new deals, Biogen bags a PhIII drug for ischemic stroke with $120M upfront
Do Not Allow Advertisers to Use My Personal information
